CLOV Quote, Financials, Valuation and Earnings

Elevance Health has a net margin of -2.77% compared to Clover Health Investments's net margin of 2.25%. Clover Health Investments's return on equity of -29.15% beat Elevance Health's return on equity of 15.67%.

Clover Health Investments has a consensus price target of $4.68, signalling upside risk potential of 43.41%. On the other hand Elevance Health has an analysts' consensus of $505.44 which suggests that it could grow by 36.21%. Given that Clover Health Investments has higher upside potential than Elevance Health, analysts believe Clover Health Investments is more attractive than Elevance Health.

Clover Health Investments has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Elevance Health has a beta of 0.828, suggesting its less volatile than the S&P 500 by 17.228%.

Clover Health Investments has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Elevance Health offers a yield of 1.76% to investors and pays a quarterly dividend of $1.63 per share. Clover Health Investments pays -- of its earnings as a dividend. Elevance Health pays out 23.3% of its earnings as a dividend. Elevance Health's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Clover Health Investments quarterly revenues are $331M, which are smaller than Elevance Health quarterly revenues of $45.1B. Clover Health Investments's net income of -$9.2M is lower than Elevance Health's net income of $1B. Notably, Clover Health Investments's price-to-earnings ratio is -- while Elevance Health's PE ratio is 13.53x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Clover Health Investments is 0.78x versus 0.50x for Elevance Health. Usually stocks with elevated PS ratios are considered overvalued.

NeueHealth has a net margin of -2.77% compared to Clover Health Investments's net margin of -24.65%. Clover Health Investments's return on equity of -29.15% beat NeueHealth's return on equity of -3241.93%.

Clover Health Investments has a consensus price target of $4.68, signalling upside risk potential of 43.41%. On the other hand NeueHealth has an analysts' consensus of -- which suggests that it could fall by -5.02%. Given that Clover Health Investments has higher upside potential than NeueHealth, analysts believe Clover Health Investments is more attractive than NeueHealth.

Clover Health Investments has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison NeueHealth has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Clover Health Investments has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. NeueHealth offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Clover Health Investments pays -- of its earnings as a dividend. NeueHealth pays out -- of its earnings as a dividend.

Clover Health Investments quarterly revenues are $331M, which are larger than NeueHealth quarterly revenues of $232.9M. Clover Health Investments's net income of -$9.2M is higher than NeueHealth's net income of -$57.4M. Notably, Clover Health Investments's price-to-earnings ratio is -- while NeueHealth's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Clover Health Investments is 0.78x versus 0.06x for NeueHealth. Usually stocks with elevated PS ratios are considered overvalued.

Oscar Health has a net margin of -2.77% compared to Clover Health Investments's net margin of -2.25%. Clover Health Investments's return on equity of -29.15% beat Oscar Health's return on equity of 2.86%.

Clover Health Investments has a consensus price target of $4.68, signalling upside risk potential of 43.41%. On the other hand Oscar Health has an analysts' consensus of $19.00 which suggests that it could grow by 40.27%. Given that Clover Health Investments has higher upside potential than Oscar Health, analysts believe Clover Health Investments is more attractive than Oscar Health.

Clover Health Investments has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Oscar Health has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Clover Health Investments has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Oscar Health offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Clover Health Investments pays -- of its earnings as a dividend. Oscar Health pays out -- of its earnings as a dividend.

Clover Health Investments quarterly revenues are $331M, which are smaller than Oscar Health quarterly revenues of $2.4B. Clover Health Investments's net income of -$9.2M is higher than Oscar Health's net income of -$54.6M. Notably, Clover Health Investments's price-to-earnings ratio is -- while Oscar Health's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Clover Health Investments is 0.78x versus 0.45x for Oscar Health. Usually stocks with elevated PS ratios are considered overvalued.

UnitedHealth Group has a net margin of -2.77% compared to Clover Health Investments's net margin of 6.11%. Clover Health Investments's return on equity of -29.15% beat UnitedHealth Group's return on equity of 14.51%.

Clover Health Investments has a consensus price target of $4.68, signalling upside risk potential of 43.41%. On the other hand UnitedHealth Group has an analysts' consensus of $636.05 which suggests that it could grow by 24.72%. Given that Clover Health Investments has higher upside potential than UnitedHealth Group, analysts believe Clover Health Investments is more attractive than UnitedHealth Group.

Clover Health Investments has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison UnitedHealth Group has a beta of 0.583, suggesting its less volatile than the S&P 500 by 41.67%.

Clover Health Investments has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. UnitedHealth Group offers a yield of 1.6% to investors and pays a quarterly dividend of $2.10 per share. Clover Health Investments pays -- of its earnings as a dividend. UnitedHealth Group pays out 30.21% of its earnings as a dividend. UnitedHealth Group's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Clover Health Investments quarterly revenues are $331M, which are smaller than UnitedHealth Group quarterly revenues of $99.2B. Clover Health Investments's net income of -$9.2M is lower than UnitedHealth Group's net income of $6.1B. Notably, Clover Health Investments's price-to-earnings ratio is -- while UnitedHealth Group's PE ratio is 33.22x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Clover Health Investments is 0.78x versus 1.22x for UnitedHealth Group. Usually stocks with elevated PS ratios are considered overvalued.